Musculoskeletal system: Latest News, Top Stories & Analysis

WASHINGTON, D.C. — The U.S. Food and Drug Administration approved the Patient Specific Talus Spacer 3D-printed talus implant for humanitarian use. The Patient Specific Talus Spacer is the first in …

FDA Approves First Therapy for Rare Disease that Causes Low Phosphate Blood Levels, Bone Softening

June 20, 2020June 20, 2020 - by MyChesCo

WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Crysvita (burosumab-twza) injection to treat patients age two and older with tumor-induced osteomalacia (TIO), a rare disease that is characterized …